Wiskott–Aldrich syndrome (WAS) is a primary immunodeficiency resulting from defective expression of the WAS protein (WASP). Up to 70% of patients with WAS also develop some form of autoimmune disease. Given the role of naturally occurring CD4+CD25+ regulatory T (TReg) cells in preventing autoimmunity, three new studies have examined the role of WASP in the development and function of TReg cells. The three groups agree that WASP has an important role in TReg cells, but they propose slightly different explanations for its effects.

Both Humblet-Baron et al. and Marangoni et al. showed that WASP is not required for the normal thymic development of TReg cells, whereas Maillard et al. found decreased numbers of TReg cells in the thymus of Wasp−/− mice, as well as in the spleen and lymph nodes. Marangoni et al. next showed that Wasp−/− TReg cells had a decreased capacity to suppress the proliferation of both wild-type and Wasp−/− effector T cells in vitro. Maillard et al. obtained similar in vitro results and further showed that, in contrast to wild-type TReg cells, Wasp−/− TReg cells could not prevent the induction of colitis by the adoptive transfer of wild-type effector T cells in vivo.

Therefore, Marangoni et al. and Maillard et al. both conclude that WASP deficiency abrogates the suppressive activity of TReg cells, and Maillard et al. also propose that the decreased production of TReg cells has a role. The defect in the suppressive activity observed for Wasp−/− TReg cells was shown to result partly from a defect in the production of transforming growth factor-β (Marangoni et al.) or interleukin-10 (IL-10) (Maillard et al.).

However, Humblet-Baron et al. showed that wild-type and Wasp−/− TReg cells mediated equivalent suppression of Wasp−/− effector T cells in vitro, but that the number of Wasp−/− TReg cells in peripheral lymphoid compartments was decreased. On the basis of three independent in vivo mouse models, they propose that WASP deficiency decreases the competitive fitness of TReg cells, rather than their function. For example, when chimeric bone marrow containing a mixture of wild-type and Wasp−/− cells was transplanted into lethally irradiated Wasp−/− mice, there was a preferential expansion of wild-type compared with Wasp−/− TReg-cell populations. The failure of adoptively transferred Wasp−/− TReg cells to engraft in wild-type hosts (Marangoni et al.) and their defective homing to peripheral lymphoid organs (Maillard et al.) also lend support to the idea that Wasp−/− TReg cells have decreased fitness.

Finally, all three groups considered the potential contribution of changes in effector T cells to the decreased activity of TReg cells in Wasp−/− mice. Wasp−/− effector T cells were not as effectively suppressed as wild-type effector T cells by wild-type TReg cells (Marangoni et al.), and both Marangoni et al. and Maillard et al. showed that the addition of exogenous IL-2 could partially rescue the suppression defect of Wasp−/− TReg cells. Humblet-Baron et al. agree that the decreased competitive fitness of Wasp−/− TReg cells could be exacerbated by decreased production of IL-2 by effector T cells in Wasp−/− mice, although this does not explain the decreased fitness of Wasp−/− TReg cells in Wasp+/− female mice.